Clinical Trials on 移植物抗宿主病 in United States
总计2333个结果
-
National Cancer Institute (NCI)终止
-
H. Lee Moffitt Cancer Center and Research InstituteGateway for Cancer Research完全的
-
Dana-Farber Cancer InstituteWyeth is now a wholly owned subsidiary of Pfizer; PDL BioPharma, Inc.终止
-
Columbia UniversityIncyte Corporation终止
-
Massachusetts General HospitalSeagen Inc.终止
-
Massachusetts Eye and Ear InfirmaryOcular Therapeutix, Inc.撤销
-
H. Lee Moffitt Cancer Center and Research InstituteNational Heart, Lung, and Blood Institute (NHLBI); CTI BioPharma完全的
-
Massachusetts General HospitalDana-Farber Cancer Institute; Seagen Inc.完全的
-
Fred Hutchinson Cancer CenterFacet Biotech未知
-
EVIVE BiotechnologyMemorial Sloan Kettering Cancer Center完全的
-
Soligenix终止Chronic Gastrointestinal Graft vs Host Disease美国
-
Soligenix终止Acute Gastrointestinal Graft vs Host Disease美国
-
Regimmune Corporation完全的
-
Novartis Pharmaceuticals完全的皮质类固醇难治性急性移植物抗宿主病德国, 日本, 沙特阿拉伯, 火鸡, 英国, 西班牙, 加拿大, 意大利, 澳大利亚, 奥地利, 法国, 大韩民国, 香港, 以色列, 荷兰, 俄罗斯联邦, 丹麦, 希腊, 台湾, 挪威, 捷克语, 保加利亚
-
University of Illinois at ChicagoNational Eye Institute (NEI); Genentech, Inc.终止
-
H. Lee Moffitt Cancer Center and Research InstituteNovartis完全的
-
National Cancer Institute (NCI)完全的
-
Fred Hutchinson Cancer CenterNational Heart, Lung, and Blood Institute (NHLBI)尚未招聘
-
Ann & Robert H Lurie Children's Hospital of ChicagoDana-Farber Cancer Institute; Fred Hutchinson Cancer Center; University of Minnesota完全的
-
Stanford University完全的